Lead Plaintiff Deadline: June 17, 2019
See If You Qualify For Monetary Reward
Please Upload related files below
Fill in below.
Looking for more?
(1) the clinical study on the use of J-Plasma for dermal resurfacing had not met its primary efficacy endpoint; (2) as a result, the clinical study did not support the Company’s application for regulatory clearance; (3) as a result, the Company was unlikely to receive regulatory approval of J-Plasma for dermal resurfacing; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.
In order to be included in the lawsuit, you must have incurred a loss on shares of purchased or acquired during the class period listed above.
If you suffered a loss in during the relevant time frame, you have until June 17, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.